Lumenis Be ANZ has launched OptiPlus in Australia and New Zealand, describing the device as “the first-ever dual frequency radiofrequency (RF) device designed specifically for eye care professionals”.
The new technology delivers therapeutic heat across multiple skin and tissue layers, boosting circulation to support both medical efficacy and aesthetic enhancement.¹
OptiPlus is designed to work synergistically with OptiLight – a light-based technology that targets the root cause of dry eye disease due to meibomian gland dysfunction (MGD).
In our study, we recorded a 150%+ increase in expressible meibomian glands, a 70% improvement in meibum quality, and over a 60% reduction in dry eye symptoms
Dual-Frequency Technology
In a media release, Lumenis said OptiPlus introduces “a novel RF approach that penetrates various skin depths, enabling targeted treatment of the meibomian glands while simultaneously stimulating collagen production and periorbital skin tightening”.1,2,3 Lumenis said this dual-action uniquely positions OptiPlus to support both therapeutic outcomes and aesthetic goals – a combination increasingly sought after by modern practices.
A standout feature of the device is its proprietary monopolar electrode, which is ergonomically designed to follow the delicate contours of the periorbital area. According to Lumenis, this ensures precision, comfort, and safety – with pre-programmed, clinically validated settings and integrated temperature control technology supporting consistent and optimal results across all skin types.4
Positive Real-World Results
Dr James Chelnis, an ophthalmologist at Manhattan Face and Eye in the United States, said he was thrilled to incorporate OptiPlus into his clinic’s treatment regimen.
As the lead investigator in a recent clinical study, he reported seeing “outstanding results using OptiLight to manage dry eye disease”.
“In our study, we recorded a 150%+ increase in expressible meibomian glands, a 70% improvement in meibum quality, and over a 60% reduction in dry eye symptoms.³ Plus, the aesthetic benefits of RF skin rejuvenation are a welcome bonus for many patients.”
Future-Ready Clinics
Tracey Cannon, Director of Marketing and Clinical Affairs, Lumenis Be ANZ, said the “first-of-its-kind technology” would become “a catalyst for transformation in both clinical practice and patient experience”.
“With OptiLight and OptiPlus working hand in hand, eye care professionals now have an extraordinary opportunity to build thriving, future-ready practices,” she concluded.
References
- Javate RM, Cruz RT Jr, Khan J, Trakos N, Gordon RE. Nonablative 4-MHz dual radiofrequency wand rejuvenation treatment for periorbital rhytides and midface laxity. Ophthalmic Plast Reconstr Surg. 2011 May-Jun;27(3):180-5. doi: 10.1097/IOP.0b013e3181fe8e5a.
- Al-Atif H. Collagen supplements for aging and wrinkles: a paradigm shift in the field of dermatology and cosmetics. Dermatol Pract Concept. 2022;12(1):e2022018. doi: 5826/dpc.1201a18.
- Chelnis J, Garcia CN, Hamza H. Multi-frequency RF combined with intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2023 Oct 20;17:3089-3102. doi: 10.2147/OPTH.S426564.
- Green JB, Dover JS, Kaminer MS. Tolerability of a monopolar radiofrequency facial skin tightening procedure: An observational study. Cosmetic Dermatology. 2011;24(7):327-330.
